PULM PE Ratio & Valuation,Is PULM Overvalued

PULM Relative Valuation

PULM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PULM is overvalued; if below, it's undervalued.

Historical Valuation

Pulmatrix Inc (PULM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.39 is considered Undervalued compared with the five-year average of -1.19. The fair price of Pulmatrix Inc (PULM) is between 165.34 to 167.54 according to relative valuation methord. Compared to the current price of 4.80 USD , Pulmatrix Inc is Undervalued By 97.1%.

Relative Value

Fair Zone

165.34-167.54

Current Price：4.80

97.1%

Undervalued

-0.94

0.00

EV/EBITDA

Pulmatrix Inc. (PULM) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-0.63

EV/EBIT

Pulmatrix Inc. (PULM) has a current EV/EBIT of -0.63. The 5-year average EV/EBIT is 0.33. The thresholds are as follows: Strongly Undervalued below -1.71, Undervalued between -1.71 and -0.69, Fairly Valued between 1.35 and -0.69, Overvalued between 1.35 and 2.38, and Strongly Overvalued above 2.38. The current Forward EV/EBIT of -0.63 falls within the Historic Trend Line -Fairly Valued range.

2.39

Pulmatrix Inc. (PULM) has a current PS of 2.39. The 5-year average PS is 4.99. The thresholds are as follows: Strongly Undervalued below -7.59, Undervalued between -7.59 and -1.30, Fairly Valued between 11.28 and -1.30, Overvalued between 11.28 and 17.56, and Strongly Overvalued above 17.56. The current Forward PS of 2.39 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Pulmatrix Inc. (PULM) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

-0.91

P/FCF

Pulmatrix Inc. (PULM) has a current P/FCF of -0.91. The 5-year average P/FCF is -1.22. The thresholds are as follows: Strongly Undervalued below -3.15, Undervalued between -3.15 and -2.18, Fairly Valued between -0.25 and -2.18, Overvalued between -0.25 and 0.71, and Strongly Overvalued above 0.71. The current Forward P/FCF of -0.91 falls within the Historic Trend Line -Fairly Valued range.

Pulmatrix Inc (PULM) has a current Price-to-Book (P/B) ratio of 3.59. Compared to its 3-year average P/B ratio of 1.36 , the current P/B ratio is approximately 163.01% higher. Relative to its 5-year average P/B ratio of 1.17, the current P/B ratio is about 207.19% higher. Pulmatrix Inc (PULM) has a Forward Free Cash Flow (FCF) yield of approximately -35.80%. Compared to its 3-year average FCF yield of -145.87%, the current FCF yield is approximately -75.46% lower. Relative to its 5-year average FCF yield of -117.78% , the current FCF yield is about -69.61% lower.

3.59

P/B

Median3y

1.36

Median5y

1.17

-35.80

FCF Yield

Median3y

-145.87

Median5y

-117.78

Competitors Valuation Multiple

The average P/S ratio for PULM's competitors is 348.96, providing a benchmark for relative valuation. Pulmatrix Inc Corp (PULM) exhibits a P/S ratio of 2.39, which is -99.32% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of PULM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of PULM in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Pulmatrix Inc (PULM) currently overvalued or undervalued?

What is Pulmatrix Inc (PULM) fair value?

PULM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Pulmatrix Inc (PULM) is between 165.34 to 167.54 according to relative valuation methord.

How does PULM's valuation metrics compare to the industry average?

What is the current P/B ratio for Pulmatrix Inc (PULM) as of Dec 15 2025?

As of Dec 15 2025, Pulmatrix Inc (PULM) has a P/B ratio of 3.59. This indicates that the market values PULM at 3.59 times its book value.

What is the current FCF Yield for Pulmatrix Inc (PULM) as of Dec 15 2025?

As of Dec 15 2025, Pulmatrix Inc (PULM) has a FCF Yield of -35.80%. This means that for every dollar of Pulmatrix Inc’s market capitalization, the company generates -35.80 cents in free cash flow.

What is the current Forward P/E ratio for Pulmatrix Inc (PULM) as of Dec 15 2025?

As of Dec 15 2025, Pulmatrix Inc (PULM) has a Forward P/E ratio of -0.94. This means the market is willing to pay $-0.94 for every dollar of Pulmatrix Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Pulmatrix Inc (PULM) as of Dec 15 2025?

As of Dec 15 2025, Pulmatrix Inc (PULM) has a Forward P/S ratio of 2.39. This means the market is valuing PULM at $2.39 for every dollar of expected revenue over the next 12 months.

PULM Valuation